Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A2OL
|
|||
| Former ID |
DNC002159
|
|||
| Drug Name |
ISIS 114390
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ARA70 messenger RNA (NCOA4 mRNA) | Target Info | . | [1] |
| KEGG Pathway | Pathways in cancer | |||
| Thyroid cancer | ||||
| Pathway Interaction Database | Coregulation of Androgen receptor activity | |||
| WikiPathways | Diurnally Regulated Genes with Circadian Orthologs | |||
| Androgen receptor signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,255,110, Antisense modulation of ARA70 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.